Results 271 to 280 of about 1,745,820 (365)
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad +35 more
wiley +1 more source
Long-term effect of neoadjuvant denosumab treatment in high-risk early breast cancer (GeparX). [PDF]
Link T +20 more
europepmc +1 more source
External Patent Exploitation in a Non-Coercive way: A case study on a multinational operating firm
Markus Eriksson
openalex +1 more source
The LINC01116 long noncoding RNA is induced by hypoxia and associated with poor prognosis and high recurrence rates in two cohorts of lung adenocarcinoma patients. Here, we demonstrate that besides its expression in cancer cells, LINC01116 is markedly expressed in lymphatic endothelial cells of the tumor stroma in which it participates in hypoxia ...
Marine Gautier‐Isola +12 more
wiley +1 more source
Patent Foramen Ovale in Children: A Review of Epidemiological Characteristics, Natural Course, and Intervention Strategies. [PDF]
Wang C, Ma L, Jin J, Shi Z.
europepmc +1 more source
ATF4‐mediated stress response as a therapeutic vulnerability in chordoma
We screened 5 chordoma cell lines against 100+ inhibitors of epigenetic and metabolic pathways and kinases and identified halofuginone, a tRNA synthetase inhibitor. Mechanistically halofuginone induces an integrated stress response, with eIF2alpha phosphorylation, activation of ATF4 and its target genes CHOP, ASNS, INHBE leading to cell death ...
Lucia Cottone +11 more
wiley +1 more source
Integrating single-cell biophysical and transcriptomic features to resolve functional heterogeneity in mantle cell lymphoma. [PDF]
Zhang Y +20 more
europepmc +1 more source
A Critical Analysis of the Proposed National Patent Board
Richard P. Cusick +3 more
openalex +1 more source

